Initial data from the outbreak in China did not reveal as much information as scientists needed to assess the epidemic. Now, more accurate data suggest an epidemic worse than some previously thought.
We’re likely to see more ‘fever clinics’ opening as coronavirus transmission takes hold in the community. But what are they? And do you need a fever to attend one?
In the week ending February 28, leading stock markets around the world faced their worst week since the financial crisis of 2008. And things could get worse.
Crisis management and business continuity plans are powerful tools for companies to remain resilient and operational when unforeseen circumstances disrupt the availability of critical infrastructure.
Communication from public health and government officials during a health threat is a critical component of preventing and treating a disease. An expert who worked on the anthrax scare explains.
At least temporarily, a kiss is no longer just a kiss. It could pass coronavirus. Even the French have suggested a ban on their traditional greeting. An expert explains why this is necessary.
Based on current available data, our model predicts by March 31, the number of deaths worldwide will surpass 4,500 and confirmed COVID-19 cases will reach about 150,000.
Peter Martin, Crawford School of Public Policy, Australian National University
Australia’s three-decade run of near continuous economic growth is set to end, with treasury warning of a hit to growth of ‘at least’ 0.5%, potentially followed by a ‘prolonged downturn’.
What can you do to keep yourself and your family safe from the coronavirus? A public health scholar explains antiseptics – and emphasizes the importance of good hand-washing.
Hand washing is a tried and true, scientifically proven preventive strategy that reduces the likelihood of transmitting both viral and bacterial borne diseases.
Honorary Enterprise Professor, School of Population and Global Health, and Department of General Practice and Primary Care, The University of Melbourne
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand